kojic acid has been researched along with B16 Melanoma in 39 studies
Excerpt | Relevance | Reference |
---|---|---|
" The two hydroxydaidzeins reduced melanin synthesis comparably to treatment with kojic acid, a proven whitening agent, in B16 melanoma cells." | 3.78 | Effects of ortho-dihydroxyisoflavone derivatives from Korean fermented soybean paste on melanogenesis in B16 melanoma cells and human skin equivalents. ( Bae, JH; Goh, MJ; Kim, DH; Kim, HK; Na, YJ; Park, JS, 2012) |
" It also inhibited melanin production by B16 melanoma cell line and normal human melanocytes more efficiently than kojic acid." | 3.77 | Dimeric cinnamoylamide derivatives as inhibitors of melanogenesis. ( Criton, M; Le Mellay-Hamon, V, 2011) |
"SF inhibited melanin synthesis in B16 melanoma cells via down-regulation of MITF and tyrosinase expression, which provides a rationale for future utilization of SF." | 1.62 | Quantitative proteomic analysis uncovers inhibition of melanin synthesis by silk fibroin via MITF/tyrosinase axis in B16 melanoma cells. ( Duan, T; Hong, M; Huang, H; Lu, Z; Wang, Y; Xiao, X; Zheng, J; Zhou, H; Zhou, Y, 2021) |
"Kojic acid (KA) is a naturally occurring fungal metabolite that is utilized as a skin-lightener and antibrowning agent owing to its potent tyrosinase inhibition activity." | 1.46 | Biodegradable Kojic Acid-Based Polymers: Controlled Delivery of Bioactives for Melanogenesis Inhibition. ( Faig, JJ; Joseph, LB; Moretti, A; Nova, MJ; Smith, K; Uhrich, KE; Zhang, Y, 2017) |
"Flavokawain analogs were synthesized through a Claisen-Schmidt condensation of their corresponding acetophenones and benzaldehydes and were evaluated in terms of their tyrosinase inhibitory and anti-melanogenesis activities." | 1.42 | Flavokawains B and C, melanogenesis inhibitors, isolated from the root of Piper methysticum and synthesis of analogs. ( Choi, J; Hong, YD; Jeong, HJ; Ko, J; Lee, CS; Lee, JH; Lee, S; Park, JS; Shin, SS; Yoon, KD, 2015) |
"Treatment with glycine (1-16 mM) for 72 h inhibited alpha-melanocyte stimulating hormone (alpha-MSH)-induced melanogenesis in a concentration-dependent manner without any effects on cell proliferation in B16F0 melanoma cells." | 1.34 | Glycine inhibits melanogenesis in vitro and causes hypopigmentation in vivo. ( Ishii, F; Ishikawa, M; Kawase, I, 2007) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (2.56) | 18.2507 |
2000's | 10 (25.64) | 29.6817 |
2010's | 27 (69.23) | 24.3611 |
2020's | 1 (2.56) | 2.80 |
Authors | Studies |
---|---|
Yamazaki, Y | 1 |
Kawano, Y | 1 |
Yamanaka, A | 1 |
Maruyama, S | 1 |
Matsuda, H | 3 |
Nakashima, S | 3 |
Oda, Y | 3 |
Nakamura, S | 3 |
Yoshikawa, M | 3 |
Thanigaimalai, P | 3 |
Lee, KC | 3 |
Bang, SC | 1 |
Lee, JH | 2 |
Yun, CY | 1 |
Roh, E | 3 |
Hwang, BY | 1 |
Kim, Y | 4 |
Jung, SH | 3 |
Xu, F | 1 |
Choi, J | 2 |
Bae, SJ | 3 |
Ha, YM | 5 |
No, JK | 1 |
Lee, EK | 2 |
Lee, JS | 1 |
Song, S | 2 |
Lee, H | 3 |
Suh, H | 2 |
Yu, BP | 1 |
Chung, HY | 7 |
Park, JY | 3 |
Park, YJ | 2 |
Park, D | 2 |
Choi, YJ | 1 |
Kim, JM | 1 |
Han, YK | 1 |
Kim, JA | 2 |
Lee, JY | 1 |
Moon, HR | 6 |
Sharma, VK | 2 |
Joo, C | 1 |
Cho, WJ | 1 |
Bandgar, BP | 1 |
Adsul, LK | 1 |
Chavan, HV | 1 |
Shringare, SN | 1 |
Korbad, BL | 1 |
Jalde, SS | 1 |
Lonikar, SV | 1 |
Nile, SH | 1 |
Shirfule, AL | 1 |
Oode, C | 1 |
Shimada, W | 1 |
Izutsu, Y | 1 |
Yokota, M | 1 |
Iwadate, T | 1 |
Nihei, K | 1 |
Jeong, HJ | 1 |
Lee, CS | 1 |
Hong, YD | 1 |
Shin, SS | 1 |
Park, JS | 2 |
Lee, S | 2 |
Yoon, KD | 1 |
Ko, J | 1 |
Liu, J | 1 |
Onishi, K | 1 |
Kawabata, M | 1 |
Miki, H | 1 |
Himuro, Y | 1 |
Wang, Y | 1 |
Duan, T | 1 |
Hong, M | 2 |
Zhou, Y | 1 |
Huang, H | 1 |
Xiao, X | 1 |
Zheng, J | 2 |
Zhou, H | 1 |
Lu, Z | 1 |
Chen, YM | 1 |
Su, WC | 1 |
Li, C | 1 |
Shi, Y | 1 |
Chen, QX | 1 |
Tang, DL | 1 |
Chen, SM | 1 |
Wang, Q | 1 |
Bang, E | 1 |
Noh, SG | 1 |
Ha, S | 1 |
Jung, HJ | 1 |
Kim, DH | 4 |
Lee, AK | 1 |
Hyun, MK | 1 |
Kang, D | 1 |
Park, C | 1 |
Ai, N | 1 |
Welsh, WJ | 1 |
Santhanam, U | 1 |
Hu, H | 1 |
Lyga, J | 1 |
Park, MH | 1 |
Kim, SJ | 2 |
Jeong, HO | 1 |
Moon, KM | 1 |
Son, S | 2 |
Kim, HR | 1 |
Kim, MJ | 1 |
Yun, HY | 2 |
Chun, P | 4 |
Je, NK | 1 |
Yokozawa, T | 2 |
Ullah, S | 1 |
Kim, YJ | 2 |
Yoo, JW | 1 |
Jung, Y | 1 |
Maack, A | 1 |
Pegard, A | 1 |
Chen, MJ | 1 |
Hung, CC | 2 |
Chen, YR | 1 |
Lai, ST | 1 |
Chan, CF | 1 |
Reddy, TL | 1 |
Garikapati, KR | 1 |
Reddy, SG | 1 |
Reddy, BV | 1 |
Yadav, JS | 1 |
Bhadra, U | 1 |
Bhadra, MP | 1 |
Faig, JJ | 1 |
Moretti, A | 1 |
Joseph, LB | 1 |
Zhang, Y | 1 |
Nova, MJ | 1 |
Smith, K | 1 |
Uhrich, KE | 1 |
Nesterov, A | 1 |
Zhao, J | 1 |
Minter, D | 1 |
Hertel, C | 1 |
Ma, W | 1 |
Abeysinghe, P | 1 |
Jia, Q | 1 |
Kai, H | 1 |
Baba, M | 1 |
Okuyama, T | 1 |
Zhang, X | 1 |
Hu, X | 1 |
Hou, A | 1 |
Wang, H | 1 |
An, SM | 1 |
Koh, JS | 1 |
Boo, YC | 1 |
Miyake, M | 1 |
Yamamoto, S | 1 |
Sano, O | 1 |
Fujii, M | 1 |
Kohno, K | 1 |
Ushio, S | 1 |
Iwaki, K | 1 |
Fukuda, S | 1 |
Criton, M | 1 |
Le Mellay-Hamon, V | 1 |
Wang, YW | 1 |
Jou, CH | 1 |
Yang, MC | 1 |
Goh, MJ | 1 |
Bae, JH | 1 |
Kim, HK | 1 |
Na, YJ | 1 |
Lajis, AF | 1 |
Hamid, M | 1 |
Ariff, AB | 1 |
Song, YM | 1 |
Ha, TK | 2 |
Park, NH | 1 |
Ohguchi, K | 1 |
Tanaka, T | 1 |
Iliya, I | 1 |
Ito, T | 1 |
Iinuma, M | 1 |
Matsumoto, K | 1 |
Akao, Y | 1 |
Nozawa, Y | 1 |
Chung, SW | 1 |
Ishikawa, M | 1 |
Kawase, I | 1 |
Ishii, F | 1 |
Kim, YM | 1 |
Yun, J | 1 |
Lee, CK | 1 |
Min, KR | 1 |
Mishima, Y | 1 |
1 review available for kojic acid and B16 Melanoma
Article | Year |
---|---|
A post melanosomal era: control of melanogenesis and melanoma growth.
Topics: Adolescent; Animals; Boron; Boron Compounds; Cricetinae; Fatty Acids, Unsaturated; Gene Expression R | 1992 |
38 other studies available for kojic acid and B16 Melanoma
Article | Year |
---|---|
N-[(Dihydroxyphenyl)acyl]serotonins as potent inhibitors of tyrosinase from mouse and human melanoma cells.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Drug Design; Drug Screening Assays, Antitumor; Enz | 2009 |
Melanogenesis inhibitors from the rhizomes of Alpinia officinarum in B16 melanoma cells.
Topics: Alpinia; Animals; Antineoplastic Agents; Enzyme Inhibitors; Flavonoids; Kaempferols; Melanoma, Exper | 2009 |
Evaluation of 3,4-dihydroquinazoline-2(1H)-thiones as inhibitors of alpha-MSH-induced melanin production in melanoma B16 cells.
Topics: alpha-MSH; Animals; Cell Line, Tumor; Drug Evaluation, Preclinical; Magnetic Resonance Spectroscopy; | 2010 |
Melanogenesis inhibitors from the desert plant Anastatica hierochuntica in B16 melanoma cells.
Topics: Agaricales; Animals; Antineoplastic Agents; Brassicaceae; Cell Proliferation; Cell Survival; Drug Sc | 2010 |
A newly synthesized, potent tyrosinase inhibitor: 5-(6-hydroxy-2-naphthyl)-1,2,3-benzenetriol.
Topics: Agaricales; Animals; Enzyme Inhibitors; Kinetics; Melanins; Melanoma, Experimental; Mice; Monophenol | 2010 |
Synthesis and biological activity of hydroxy substituted phenyl-benzo[d]thiazole analogues for antityrosinase activity in B16 cells.
Topics: Agaricales; Animals; Benzothiazoles; Binding Sites; Catalytic Domain; Cell Line, Tumor; Computer Sim | 2011 |
Ketonethiosemicarbazones: structure-activity relationships for their melanogenesis inhibition.
Topics: Animals; Cell Line, Tumor; Hydrophobic and Hydrophilic Interactions; Inhibitory Concentration 50; Ke | 2011 |
Structural requirement of phenylthiourea analogs for their inhibitory activity of melanogenesis and tyrosinase.
Topics: Agaricales; Animals; Catalytic Domain; Cell Line, Tumor; Enzyme Inhibitors; Humans; Melanins; Melano | 2011 |
Synthesis, biological evaluation, and molecular docking of N-{3-[3-(9-methyl-9H-carbazol-3-yl)-acryloyl]-phenyl}-benzamide/amide derivatives as xanthine oxidase and tyrosinase inhibitors.
Topics: Animals; Benzamides; Carbazoles; Cell Survival; Dose-Response Relationship, Drug; Enzyme Inhibitors; | 2012 |
Synthesis of dihydroresveratrol glycosides and evaluation of their activity against melanogenesis in B16F0 melanoma cells.
Topics: Animals; Cell Line, Tumor; Drug Screening Assays, Antitumor; Glycosides; Magnetic Resonance Spectros | 2014 |
Flavokawains B and C, melanogenesis inhibitors, isolated from the root of Piper methysticum and synthesis of analogs.
Topics: Animals; Flavonoids; Humans; Kava; Melanins; Melanoma, Experimental; Mice; Structure-Activity Relati | 2015 |
Inhibitors of melanogenesis in B16 melanoma 4A5 cells from flower buds of Lawsonia inermis (Henna).
Topics: Animals; Antifibrinolytic Agents; Cell Line, Tumor; Cell Proliferation; Flavonoids; Flowers; Humans; | 2015 |
Quantitative proteomic analysis uncovers inhibition of melanin synthesis by silk fibroin via MITF/tyrosinase axis in B16 melanoma cells.
Topics: Animals; Fibroins; Melanins; Melanoma, Experimental; Mice; Microphthalmia-Associated Transcription F | 2021 |
Anti-melanogenesis of novel kojic acid derivatives in B16F10 cells and zebrafish.
Topics: Agaricales; Animals; Cell Shape; Melanins; Melanoma, Experimental; Mice; Microphthalmia-Associated T | 2019 |
Evaluation of the Novel Synthetic Tyrosinase Inhibitor (
Topics: Agaricales; Animals; Cell Survival; Chromans; Computer Simulation; Drug Design; Enzyme Inhibitors; I | 2018 |
Novel virtual screening approach for the discovery of human tyrosinase inhibitors.
Topics: Agaricales; Algorithms; Animals; Cell Line, Tumor; Drug Discovery; Enzyme Inhibitors; Fungal Protein | 2014 |
Inhibition of melanogenesis by 2-[4-(5-chlorobenzo[d]thiazol-2-yl)phenoxy]-2-methylpropanoic acid (MHY908).
Topics: Agaricales; Animals; Cell Survival; Dose-Response Relationship, Drug; Enzyme Inhibitors; Melanins; M | 2015 |
Design, synthesis, and anti-melanogenic effects of (E)-2-benzoyl-3-(substituted phenyl)acrylonitriles.
Topics: Acrylonitrile; Agaricales; Animals; Binding Sites; Cell Line, Tumor; Dose-Response Relationship, Dru | 2015 |
Populus nigra (Salicaceae) absolute rich in phenolic acids, phenylpropanoïds and flavonoids as a new potent tyrosinase inhibitor.
Topics: Agaricales; Animals; Flavonoids; Humans; Hydroxybenzoates; Melanins; Melanocytes; Melanoma, Experime | 2016 |
Novel synthetic kojic acid-methimazole derivatives inhibit mushroom tyrosinase and melanogenesis.
Topics: Agaricales; Animals; Biphenyl Compounds; Chick Embryo; Enzyme Inhibitors; Melanins; Melanoma, Experi | 2016 |
Simultaneous delivery of Paclitaxel and Bcl-2 siRNA via pH-Sensitive liposomal nanocarrier for the synergistic treatment of melanoma.
Topics: Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Cell Line, Tumor; Drug Compounding; Drug Deli | 2016 |
Biodegradable Kojic Acid-Based Polymers: Controlled Delivery of Bioactives for Melanogenesis Inhibition.
Topics: Animals; Biocompatible Materials; Cell Survival; Drug Delivery Systems; Melanins; Melanoma, Experime | 2017 |
1-(2,4-dihydroxyphenyl)-3-(2,4-dimethoxy-3-methylphenyl)propane, a novel tyrosinase inhibitor with strong depigmenting effects.
Topics: Agaricales; Animals; Antioxidants; Cell Line; Dermatologic Agents; Enzyme Inhibitors; Kinetics; Lili | 2008 |
Inhibitory effect of Cucumis sativus on melanin production in melanoma B16 cells by downregulation of tyrosinase expression.
Topics: Animals; Antioxidants; Cucumis sativus; Hyperpigmentation; Melanins; Melanoma, Experimental; Mice; M | 2008 |
Inhibitory effect of 2,4,2',4'-tetrahydroxy-3-(3-methyl-2-butenyl)-chalcone on tyrosinase activity and melanin biosynthesis.
Topics: alpha-MSH; Animals; Antioxidants; Cell Line, Tumor; Cell Survival; Chalcone; Dopamine Agents; Dose-R | 2009 |
p-coumaric acid not only inhibits human tyrosinase activity in vitro but also melanogenesis in cells exposed to UVB.
Topics: Agaricales; Animals; Arbutin; Cells, Cultured; Coumaric Acids; Dihydroxyphenylalanine; Epidermal Cel | 2010 |
Inhibitory effects of 2-amino-3H-phenoxazin-3-one on the melanogenesis of murine B16 melanoma cell line.
Topics: Agaricales; Animals; Cell Line, Tumor; Indoles; Melanins; Melanoma; Melanoma, Experimental; Mice; Mi | 2010 |
Dimeric cinnamoylamide derivatives as inhibitors of melanogenesis.
Topics: Animals; Cell Line; Cell Line, Tumor; Coumaric Acids; Dermatologic Agents; Dimerization; Ethylenedia | 2011 |
Cellular fusion and whitening effect of a chitosan derivative coated liposome.
Topics: Animals; Antioxidants; Cell Fusion; Cell Line, Tumor; Cell Proliferation; Chitin; Cholesterol; Fibro | 2012 |
Effects of ortho-dihydroxyisoflavone derivatives from Korean fermented soybean paste on melanogenesis in B16 melanoma cells and human skin equivalents.
Topics: Animals; Antineoplastic Agents, Phytogenic; Cell Proliferation; Cell Survival; Enzyme Activation; Fe | 2012 |
Depigmenting effect of Kojic acid esters in hyperpigmented B16F1 melanoma cells.
Topics: Animals; Cell Line, Tumor; Dose-Response Relationship, Drug; Esters; Melanins; Melanoma, Experimenta | 2012 |
Design, synthesis, and evaluation of (E)-N-substituted benzylidene-aniline derivatives as tyrosinase inhibitors.
Topics: Agaricales; alpha-MSH; Aniline Compounds; Animals; Antineoplastic Agents; Benzylidene Compounds; Cat | 2012 |
A novel synthesized tyrosinase inhibitor: (E)-2-((2,4-dihydroxyphenyl)diazenyl)phenyl 4-methylbenzenesulfonate as an azo-resveratrol analog.
Topics: Animals; Azo Compounds; Benzenesulfonates; Cell Line, Tumor; Cell Survival; Dose-Response Relationsh | 2013 |
Gnetol as a potent tyrosinase inhibitor from genus Gnetum.
Topics: Animals; Gnetum; Inhibitory Concentration 50; Melanins; Melanoma, Experimental; Mice; Peptides; Pyro | 2003 |
4-(6-Hydroxy-2-naphthyl)-1,3-bezendiol: a potent, new tyrosinase inhibitor.
Topics: Agaricales; Animals; Cell Survival; Dose-Response Relationship, Drug; Enzyme Inhibitors; Hydroquinon | 2007 |
Piceatannol inhibits melanogenesis by its antioxidative actions.
Topics: Animals; Antioxidants; Cell Line, Tumor; Dose-Response Relationship, Drug; Down-Regulation; Glutathi | 2007 |
Glycine inhibits melanogenesis in vitro and causes hypopigmentation in vivo.
Topics: alpha-MSH; Amino Acids; Animals; Antioxidants; Cell Line, Tumor; Dose-Response Relationship, Drug; F | 2007 |
Oxyresveratrol and hydroxystilbene compounds. Inhibitory effect on tyrosinase and mechanism of action.
Topics: Agaricales; Animals; Antioxidants; Enzyme Inhibitors; Gene Expression Regulation, Enzymologic; Kinet | 2002 |